No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.3x · 10Y median 0.4x · 16th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 12
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-23T22:45:30.593Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Amentum Holdings, Inc. (AMTM) stock was $19.71 as of Sep 23, 2026, 4:00 PM EDT, up 0.05% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -18.8%
Amentum Holdings, Inc. is a provider of critical, technology-driven services, serving both governmental and commercial sectors.
Aerospace & Defense · Chantilly, VA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 23, 2026
61 days away
EPS Estimate
0.66
Revenue Est.
$3.70B
Last Quarter Results
EPS
$0.67
vs Estimate
$0.61
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AMTM | $4.81B | $19.71 | +0.05% | -18.76% | N/A | N/A | N/A |
| 2UNF | $4.68B | $257.62 | -2.79% | +59.95% | +4.94% | +8.43% | vs AMTM |
| 3MYRG | $4.60B | $295.18 | +2.12% | +62.61% | +22.18% | +26.20% | vs AMTM |
| 4KBR | $4.46B | $35.34 | +0.94% | -24.84% | -0.27% | +11.16% | vs AMTM |
| 5CECO | $4.38B | $74.98 | +1.73% | +64.43% | +62.63% | +28.85% | vs AMTM |
| 6CWST | $5.31B | $84.80 | -1.12% | -3.04% | +3.44% | +25.90% | vs AMTM |
1.02
$3.49B
vs Estimate
$3.57B
Consensus Rating
Based on 12 analysts
Average Price Target
$29.58
+50.1% upside
Low
$21.00
Current
$19.71
High
$40.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.62 | $0.66 | $0.69 | 6 |
| Quarter ending Jan 2027 | $0.56 | $0.58 | $0.59 | 5 |
| Quarter ending Apr 2027 | $0.63 | $0.63 | $0.65 | 1 |
| Quarter ending Jul 2027 | $0.65 | $0.66 | $0.67 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $2.42 | $2.45 | $2.49 | 6 |
| FY 2027 | $2.50 | $2.64 | $2.84 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $3.67B | $3.70B | $3.71B | 5 |
| Quarter ending Jan 2027 | $3.30B | $3.32B | $3.36B | 4 |
| Quarter ending Apr 2027 | $3.44B | $3.47B | $3.52B | 2 |
| Quarter ending Jul 2027 | $3.47B | $3.50B | $3.55B | 2 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Oct 3, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $13.89B | $13.91B | $13.93B | 7 |
| FY 2027 | $13.94B | $14.05B | $14.13B | 8 |
